Size | Price | Stock | Qty |
---|---|---|---|
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
5g |
|
||
Other Sizes |
|
Purity: ≥98%
Bendazac (trade name Nevanac among others) is a NSAID (nonsteroidal anti-inflammatory drug) approved for use as a prescription eye drop 0.1% solution or 0.3% solution. It is used to treat pain and inflammation associated with cataract surgery. Nepafenac is a prodrug of amfenac, acting as an inhibitor of COX-1 and COX-2 enzymes. It has to be converted to amfenac by ocular tissue hydrolases after penetration via the cornea.
ln Vitro |
Bendazak is an anti-inflammatory drug that effectively treats a range of inflammatory skin conditions because of its protein-antidenaturing qualities. It has been demonstrated that bendazak is a highly reactive substrate in chemical oxidation systems that resemble the biological processes involved in the production of hydroxyl radicals [2]. Bendazak was demonstrated to inhibit the denaturation of bovine serum albumin (BSA) by urea, heat, and free radicals produced in the xanthine/xanthine oxidase system through the use of EPR spectroscopy of spin-labeled BSA [2].
|
---|---|
References |
[1]. Balfour JA, et al. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs. 1990;39(4):575-596.
[2]. Guglielmotti A, et al. Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent. Pharmacol Res. 1995;32(6):369-373. [3]. Musci G, et al. Mechanism of the scavenger-like activity of bendazac. Drugs Exp Clin Res. 1987;13(5):289-292. |
Molecular Formula |
C16H14N2O3
|
---|---|
Molecular Weight |
282.299
|
Exact Mass |
282.1004
|
CAS # |
20187-55-7
|
Related CAS # |
Bendazac L-Lysine;81919-14-4
|
SMILES |
O(C([H])([H])C(=O)O[H])C1C2=C([H])C([H])=C([H])C([H])=C2N(C([H])([H])C2C([H])=C([H])C([H])=C([H])C=2[H])N=1
|
Synonyms |
Bendazolic acidIlevro AmnacNevanac1-Benzylindazole-3-oxyacetic acid Zildasac Versus
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~250 mg/mL (~885.61 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (7.37 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (7.37 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.5423 mL | 17.7117 mL | 35.4233 mL | |
5 mM | 0.7085 mL | 3.5423 mL | 7.0847 mL | |
10 mM | 0.3542 mL | 1.7712 mL | 3.5423 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.